Keto Diet Raises Small-Intestine Tumor Risk in Mice, MIT Study Finds
A ketogenic diet increases small-intestinal tumors in cancer-prone mice while reducing colon tumors, pointing to stem-cell effects rather than ketones.
Clinical AI, drug discovery, devices, and regulatory approvals.
A ketogenic diet increases small-intestinal tumors in cancer-prone mice while reducing colon tumors, pointing to stem-cell effects rather than ketones.
A brief comfortable walk triggers measurable intestinal activity within minutes, suggesting a simple non-drug aid for constipation.
A new study in zebrafish and mouse embryos reveals that E-cadherin, known for holding cells together, also plays a key role in clearing dead cells.
A new analysis argues that pharma's focus on efficiency over reinvention is widening its gap with digital health.
Three women developed temporary neurological symptoms after receiving injections from an unapproved botulinum toxin product at a Colorado med spa, prompting a public health investigation.
A regulatory disclosure raises questions about a new pancreatic cancer drug's breadth, while analysts see an amylin analog as mostly a maintenance therapy.
The World Health Organization confirmed 8,728 cases and 4,205 deaths in the Democratic Republic of Congo's Ebola outbreak caused by the Bundibugyo virus.
The biotech adds a clinical development leader who previously held the same role at Enveda Therapeutics.
A recent XBI slide reflects clinical, rate, and election worries, while private biotech buyouts hit record levels.
The approval adds immunotherapy to adjuvant chemotherapy for a molecularly defined subset of colon cancer, cutting recurrence risk by half.
A study of children with acute gastroenteritis found that higher recent temperatures were associated with a lower likelihood of a viral cause, suggesting weather data could aid diagnosis.
The company shared updates on its experimental cellular reprogramming therapy for glaucoma, a notable step for a once-controversial approach.
A Cochrane review finds that industry payments and promotional materials increase inappropriate prescriptions and costs, while conflict-of-interest policies help.
New CMS quality ratings for Medicare Advantage plans reward Humana with a major rebound while Alignment Healthcare faces a steep drop and a threatened lawsuit.
A review of 80 clinical trials with nearly 30,000 participants finds nicotine e-cigarettes more effective for quitting than standard nicotine replacement therapies.
A comparison of five natural compounds found curcumin most effective at disrupting cancer cell energy and halting division.
A Harvard epidemiologist warns that untested 2030 census rule changes would artificially inflate disease rates and harm health planning.
A public health researcher adapted her dissertation to analyze Reddit conversations, revealing how the end of Roe reshaped real-world barriers to abortion care.